BUFFALO, New York, July 1 -- The University at Buffalo (State University of New York) posted the following news release:

* * *

For patients with Afib and Type 2 diabetes, GLP-1 drugs outperform SGLT-2 drugs

Observational study of 18,000 patients finds 36% lower risk of premature death 

By Laurie Kaiser

Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney disease an . . .

Click here for more information about our products